AstraZeneca
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
AstraZeneca
Jul 22, 2024, 16:46 |
Insight
Friends HRD Harmonization Project with Patsy Hinson - Friends of Cancer Research
Friends of Cancer Research shared on X: "It is very important for patients to have…
Jul 21, 2024, 20:40 |
Blog
Leora Horn: On the progress we are making in earlier lung cancer detection and treatment
Cristian Massacesi, Chief Medical Officer and Oncology Chief Development Officer at AstraZeneca, shared a post…
Jul 21, 2024, 11:38 |
Blog
Juan Domingo Gispert: AstraZeneca is hiring an Director of Clinical Imaging, Early Clinical Development
Juan Domingo Gispert, Director of Clinical Imaging, Early Clinical Development at AstraZeneca, shared on LinkedIn: "…
Jul 20, 2024, 12:01 |
Blog
Join AstraZeneca Barcelona Hub's growing team
Michele Moschetta, Executive Director of Early Clinical Development Oncology at Barcelona AstraZeneca R and D…
Jul 19, 2024, 14:44 |
Blog
"What’s Next for Immunotherapies?" by Anas Younes
Anas Younes shared a post on LinkedIn: Immunotherapies Immunotherapies "My interview with Mark Cobbold, Senior…
Jul 18, 2024, 10:05 |
Insight
EMA Joins FDA: Osimerintib + Chemo Approved for EGFR-Mutated Lung Cancer
Breaking News: EMA Joins FDA in Approving Osimerintib with Chemotherapy as a New 1st-Line Treatment…
Jul 17, 2024, 09:05 |
Societies
The Global Breast Cancer Initiative Framework is being implemented - City Cancer Challenge
City Cancer Challenge shared on LinkedIn: "Thanks to the collaboration between C/Can and the World…
Jul 15, 2024, 12:19 |
Insight
Maurizio Scaltriti: Thrilled to have been invited o deliver a seminar at the Centre for Genomic Regulation
Maurizio Scaltriti, Vice President of Translational Medicine at AstraZenica, shared a post on LinkedIn: “I’m…
Jul 15, 2024, 11:47 |
Positive
David Fredrickson: As I reflect on an incredible decade with AstraZeneca, what I feel most is gratitude
David Fredrickson, Executive Vice-President, Oncology Business at AstraZeneca, shared on LinkedIn: "Do you remember what…
Jul 13, 2024, 05:22 |
Blog
2024 Equity in Access Research Program Grantees of The Leukemia and Lymphoma Society
The Leukemia and Lymphoma Society shared on X: “Let's applaud our 2024 Equity in Access…
Jul 9, 2024, 18:09 |
Blog
Daniel Neumeier: Biopharma acquisitions H1/24
Daniel Neumeier, Life Sciences Specialist at L.E.K. Consulting, shared on LinkedIn: "Biopharma acquisitions H1/24 Number…
Jul 4, 2024, 12:43 |
Opinion
Mohit Manrao: When it comes to the world of AI, optimism drives my perspective
Mohit Manrao, SVP, Head of US Oncology at AstraZeneca, shared on LinkedIn: "When it comes…
Jul 4, 2024, 11:05 |
Blog
Christoph Varenhorst: Reflecting on a Quarter Century of Impact in Healthcare
Christoph Varenhorst, Global Vice President at AstraZeneca, shared a post on LinkedIn: . "Reflecting on…
Jul 2, 2024, 15:28 |
Blog
Sarah Louden: 2024 ASCO Direct Puerto Rico is an overwhelming success
Sarah Louden, Founder and CEO of Total Health, shared on LinkedIn: "Excellent! Stupendous! The 2024 ASCO…
Jun 30, 2024, 04:34 |
Positive
Karen Knudsen: Thankful for the incredible partnership with AstraZeneca as we improve lives, together
David Fredrickson, Executive Vice-President of the Oncology Business at AstraZeneca, shared a post on LinkedIn:…
Jun 29, 2024, 09:45 |
Blog
$130,000 Grant From The AACR-AstraZeneca Endometrial Cancer Research Fellowship - American Association for Cancer Research
American Association for Cancer Research shared a post on LinkedIn: “The AACR-AstraZeneca Endometrial Cancer Research…
Jun 28, 2024, 14:34 |
Blog
María Natalia Gandur Quiroga: Imfinzi Shows Significant Survival Benefits in NIAGARA Phase III Trial
María Natalia Gandur Quiroga shared on LinkedIn: . "Imfinzi Shows Significant Survival Benefits in NIAGARA…
Jun 27, 2024, 14:17 |
Insight
Mohit Manrao: Positive high-level results from the NIAGARA Phase 3 study with IO in MIBC
Mohit Manrao, SVP, Head of US Oncology at AstraZeneca, shared on LinkedIn: “This content is…
Jun 26, 2024, 08:30 |
Insight
IMFINZI (durvalumab) showed improved EFS and OS for MIBC in NIAGARA Phase III trial
First immunotherapy regimen before and after surgery to extend survival in bladder cancer Positive high-level results…
Jun 22, 2024, 04:45 |
Blog
Susan Galbraith: I am passionate about supporting the next generation of female leaders in STEM
Susan Galbraith, Executive Vice President in Oncology R&D at AstraZeneca, shared on LinkedIn: "It was…
Jun 16, 2024, 03:34 |
Blog
Benjamin Toll: AACR-AstraZeneca Breast Cancer Research Fellowship for Endocrine Therapy Research
Benjamin Toll, Associate Director of Education at MUSC Hollings Cancer Center, shared a post on X…
Jun 15, 2024, 05:25 |
Blog
Leora Horn: An update on our recent review published in Trends in Cancer
Leora Horn, Head of Clinical Development, Late Oncology at AstraZeneca, shared a post on LinkedIn: "Together…
Jun 12, 2024, 03:30 |
Blog
Rasha Aboelhassan: Solving debates for the treatment of stage III inoperable lung cancer is challenging
Rasha Aboelhassan shared on LinkedIn: "For decades, solving debates for the treatment of stage III…
Jun 11, 2024, 14:31 |
Insight
Sofia Tzamarelou: Georgi Ivanov wrote a fantastic piece on ASCO 2024
Sofia Tzamarelou, Senior Consultant at Commetric, shared on LinkedIn: “Our very own Georgi Ivanov wrote…
Jun 11, 2024, 12:19 |
Career
Jane B. is starting a new position as Medical Affairs Lead, Precision Oncology at AstraZeneca!
Jane B., Medical Affairs Lead, Precision Oncology at AstraZeneca, shared on LinkedIn: “I’m happy to…
Jun 11, 2024, 11:49 |
Blog
Cristian Massacesi: Very much enjoyed being part of the Endpoints panel at ASCO2024
Cristian Massacesi, Chief Medical Officer and Oncology Chief Development Officer at AstraZeneca, posted on LinkedIn:…
Jun 10, 2024, 06:58 |
Blog
Yasmine Hassan: Just wrapped up an amazing ASCO conference, now gearing up for the upcoming EHA
Yasmine Hassan, Global Patient Affairs Director at AstraZeneca, made the following post on LinkedIn: "Just…
Jun 9, 2024, 15:31 |
Insight
Erin Phillips: Reflections from ASCO24 by Erik Schrader
Erin Phillips, Franchise Head Lung and IO at AstraZeneca, shared on X: …
Jun 8, 2024, 06:42 |
Blog
Magdy Wahib: My key reflections from ASCO 2024
Magdy Wahib, International Medical Director (Gyn and Breast Cancers) at AstraZeneca, posted on LinkedIn: "As ASCO…
Jun 7, 2024, 16:55 |
Career
Sunil Verma: Day 1 in AstraZeneca as SVP, Global Head, Oncology Franchise
Sunil Verma shared on X: . "Day 1 in the…
Jun 6, 2024, 11:16 |
Blog
Herbert Loong: A pleasure to collaborate with Dr. Fernando Lopez-Rios and Dr. Alicia Morgans
Herbert Loong shared a post by Precision Oncology CONNECT on LinkedIn: "A pleasure to have…
Jun 6, 2024, 07:37 |
Insight
Ingrid Mayer: 2024 marks my third ASCO with AstraZeneca!
Ingrid Mayer, Vice-President, Global Clinical Strategy Head of Breast and Gynecological Cancers at AstraZeneca, shared…
Jun 6, 2024, 03:29 |
Blog
Micah Maxwell: We all strive together towards the common goal of eliminating cancer
Micah Maxwell, Senior Global Development Medical Director at AstraZeneca, shared on LinkedIn: . "As…
Jun 6, 2024, 02:02 |
Insight
Magdy Wahib: We carry the responsibility of sharing what we have learned
Magdy Wahib, International Medical Director (Gynaecological and Breast Cancers) at AstraZeneca, shared on LinkedIn: “As…
Jun 4, 2024, 09:59 |
Blog
Marco Gymnopoulos: Looking for an associate director for my solid tumor ADC portfolio team at AstraZeneca
Marco Gymnopoulos, Director ADC Portfolio at AstraZeneca, shared a post on LinkedIn: ''Hiring: I am…
Jun 4, 2024, 08:23 |
Blog
James Hadfield: Looking forward to speaking at FOGBoston
James Hadfield, Director of Epigenomics Oncology Translational Medicine at AstraZeneca, posted on X: "Looking forward…
Jun 3, 2024, 22:53 |
Insight
Paul Healy: AstraZeneca and Daiichi Sankyo have announced positive results from datopotamab deruxtecan in certain lung cancer patients
Paul Healy, Director of PHARMeMED, shared on LinkedIn: "AstraZeneca (AZ) and Daiichi Sankyo have announced positive…
May 31, 2024, 10:52 |
Blog
AstraZeneca is one of the industry partners supporting the AACR Clinical Oncology Research (CORE) Training Fellowship
AACR shared a post on LinkedIn: "AstraZeneca is one of the industry partners supporting the AACR…
May 29, 2024, 06:28 |
Blog
Cristian Massacesi: Another memorable congress for AstraZeneca to present over 100 abstracts at ASCO 24
Cristian Massacesi, Chief Medical Officer and Oncology Chief Development Officer at AstraZeneca, posted on LinkedIn:…
May 29, 2024, 06:16 |
Blog
Nana Scotto: ASCO is not just a congress
Nana Scotto, Vice President & Global Head Medical Affairs Oncology at AstraZeneca, made the following…
May 29, 2024, 03:38 |
Blog
The AACR-AstraZeneca Endometrial Cancer Research Fellowship
AACR shared on LinkedIn: "The AACR- AstraZeneca Endometrial Cancer Research Fellowship is a two-year, $130,000 grant…
May 27, 2024, 12:39 |
Societies
Selin Kurnaz: Massive Bio and Precision Cancer Consortium's collaborative abstract accepted at ASCO24
Selin Kurnaz, Co-Founder and CEO at Massive Bio, shared on LinkedIn: "I am beyond proud…
May 25, 2024, 11:20 |
Blog
Greg Rossi: some thoughts in Euractiv about the urgent need to address cancer in Europe
Greg Rossi, Senior Vice President of Oncology Europe and Canada at AstraZeneca, shared a post on…
May 24, 2024, 01:22 |
Blog
Tanja Obradovic on Radiopharmaceuticals in oncology
Tanja Obradovic shared a post on LinkedIn: "Radiopharmaceuticals in oncology have been recently very active clinical…
May 20, 2024, 11:14 |
Drugs
AstraZeneca announces plans for a $1.5 billion manufacturing facility in Singapore for ADCs
AstraZeneca shared on LinkedIn: "We are excited to announce our plans for a $1.5 billion…
May 16, 2024, 16:51 |
Insight
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
In the fast-growing field of oncology, we are witnessing significant advances in several treatment modalities…
May 15, 2024, 12:30 |
Blog
Joshua Omale: Leading the next leg of our 'Adopt a School NCDs Project' at Zololo Secondary School
Joshua Omale, Campus President at Slum and Rural Health Initiative Network, shared a post on…
May 13, 2024, 07:19 |
Blog
Joshua Omale: Empowering the Next Generation to Combat Non-Communicable Diseases - A Personal Action
Joshua Omale shared on LinkedIn: "Empowering the Next Generation to Combat Non-Communicable Diseases: A Personal…
May 11, 2024, 13:41 |
Blog
Jorge Reis-Filho: A great opportunity to learn more about the exciting work being done at AstraZeneca
Jorge Reis-Filho, Vice President, Cancer Biomarker Development at AstraZeneca, shared a post by Diana Merino…
May 11, 2024, 11:44 |
Blog
Inocras Inc. announces collaboration with AstraZeneca and the Cancerinformation.com.hk Charity Foundation
Inocras Inc. shared on LinkedIn: "We're thrilled to announce our collaboration with AstraZeneca and the Cancerinformation.com.hk…
May 10, 2024, 15:58 |
Blog
Sunil Verma: Great to be at the Milken Institute Global Conference in Los Angeles!
Sunil Verma, Senior Vice President of Global Head of Oncology at AstraZeneca, shared on LinkedIn: “Great…
May 10, 2024, 12:08 |
Blog
Sunil Verma: Great to be at the Milken Institute Global Conference in Los Angeles!
Sunil Verma, Senior Vice President of Global Head of Oncology at AstraZeneca, shared on LinkedIn: "Great…
May 6, 2024, 14:07 |
Blog
Vanessa Kerry: My remarks from the Climate and Health Day
Vanessa Kerry, CEO of Seed Global Health, posted on LinkedIn: "Thank you National Academy of…
May 5, 2024, 07:05 |
Blog
Deepak Arora: I am excited to announce the launch of Cancer Care Africa
Deepak Arora, Country President of African Cluster at AstraZeneca, shared a post on LinkedIn: "Yesterday was…
May 4, 2024, 10:27 |
Insight
Paolo Tarantino: HER2 is about to change again
Paolo Tarantino shared a previous post of him on X and added: "HER2 is about…
Apr 25, 2024, 15:40 |
Blog
BioTrinity 2024 in the City of London - The Institute of Cancer Research
The Institute of Cancer Research shared a post on LinkedIn: "Calling companies and potential partners…
Apr 25, 2024, 14:41 |
Blog
Cristian Massacesi: I’m proud to share that AstraZeneca was named one of the winners of Bio-IT World's Innovative Practices Awards at Bio-IT Expo in Boston
Cristian Massacesi, Chief Medical Officer and Oncology Chief Development Officer at AstraZeneca, posted on LinkedIn:…
Apr 25, 2024, 12:59 |
Societies
Chitkala Kalidas: It was a pleasure participating in the industry panel discussion at Cancer Drug Development Forum
Chitkala Kalidas, Vice President, Global Head of Oncology at Bayer shared a post on LinkedIn:…
Apr 23, 2024, 10:26 |
Career
Elizabeth Klemm: I’m excited to share that I’ve joined AstraZeneca in the Vaccines and Immune Therapies team as Associate Director, Clinical Information Practice
Elizabeth Klemm, Associate Director of Vaccines and Immune Therapies at AstraZeneca, shared on LinkedIn: "I’m…
Apr 21, 2024, 10:22 |
Blog
Sunil Verma: I am proud to share that AstraZeneca and Charities Aid Foundation (CAF) have launched a new grant programme
Sunil Verma, Senior Vice President of Global Head of Oncology at AstraZeneca, shared on LinkedIn: “I…
Apr 16, 2024, 00:17 |
Blog
Paolo Tarantino: We review best practices and future perspectives for the identification of patients with HER2-low Breast Cancer
Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, posted on LinkedIn: "In our latest…
Apr 12, 2024, 05:16 |
Drugs
Tanja Obradovic: Era of antibody drug conjugates just got even more exciting with the first tumor-agnostic approval for ADC
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON, recently shared on LinkedIn: "Era…
Apr 11, 2024, 14:45 |
Insight
Wafik El-Deiry: Susan Galbraith speaks about AstraZeneca oncology portfolio and collaboration opportunities at the AACR Oncology Industry Partnering Event in San Diego
Wafik El-Deiry, Director of the Legorreta Cancer Center at Brown University, recently posted on LinkedIn:…
Apr 10, 2024, 09:44 |
Blog
,
Career
Sunil Verma: Thrilled to have Mimi Huizinga join our Oncology Medical leadership team at The AstraZeneca
Sunil Verma, SVP, Global Head of Oncology, Medical at AstraZeneca, shared a post by Mimi Huizinga,…
Apr 8, 2024, 16:20 |
Drugs
Rami Manochakian: BIG NEWS press release by AstraZeneca!
Rami Manochakian, Thoracic Medical Oncologist at Mayo Clinic, shared a post on X: “Hot Off…
Apr 8, 2024, 14:26 |
Insight
Shubh Goel: ADRIATIC Phase III trial for LS-SCLC couldn’t come at a more critical time for patients
Shubh Goel, VP and US Franchise Head, Immuno-Oncology and GI Tumors at AstraZeneca, shared a post…
Apr 6, 2024, 08:45 |
Insight
Wafik S. El-Deiry: Dr. Susan Galbraith speaks about AstraZeneca oncology portfolio and collaboration opportunities at the AACR Oncology Industry Partnering Event in San Diego
Mar 16, 2024, 14:58 |
Blog
Lung Cancer Research Foundation has announced three research grant awards funded by Daiichi Sankyo and AstraZeneca
Haichuan Hu, Director of Early Clinical Development - Hematology, Oncology and Cell Therapy at Bristol…
Mar 10, 2024, 23:29 |
Blog
Rasha Aboelhassan: TOPAZ study has discovered a new line of treatment that significantly improves overall and progression-free survival
Rasha Aboelhassan, Senior Oncology Consultant at Nasser Institute Hospital, shared on LinkedIn: “Biliary tract cancer is a…
Mar 3, 2024, 16:42 |
Blog
Vivek Subbiah: Thrilled to announce a groundbreaking - AstraZeneca and Sarah Cannon Docs collaboration
Vivek Subbiah shared a post on X: "Exciting News in Clinical Trials! Thrilled to announce…
Feb 27, 2024, 05:27 |
Blog
Shubh Goel: Recently, I spoke to a Pharmaceutical Executive following data presented at ASCO GI from our EMERALD-1 and MATTERHORN Phase III trials
Shubh Goel, VP and US Franchise Head, Immuno-Oncology and GI Tumors at AstraZeneca, shared a…
Feb 23, 2024, 14:31 |
Blog
Rasika Bombatkar: The rejection of my application for adjuvant Osimertinib is disheartening to say the least
Rasika Bombatkar, Citizen Scientist at LUNGevity Foundation, cancer patient and advocate, shared on X: "AstraZeneca,…
Feb 17, 2024, 16:20 |
Career
Sunil Verma: Francisco J Peña's project will focus on developing AI-based tools for precision medicine in cancer
Sunil Verma, SVP, Global Head of Oncology at AstraZeneca, shared a post by Mattias Rantalainen on…
Feb 5, 2024, 13:25 |
Blog
Sunil Verma: World Cancer Day holds a deeply personal significance to me as an oncologist
Sunil Verma, Global Head of Oncology of Medical AstraZeneca, shared a post on LinkedIn: “World…
Jan 31, 2024, 18:01 |
Blog
Alessandro Isidori: Every success only serves to bring about an even greater one
Alessandro Isidori, Hematologist at the Hematology and Stem Cell Transplant Center of the AORMN Hospital,…
Jan 22, 2024, 13:58 |
Insight
Percy Lee: HyCRT-SABR for unresectable locally advanced NSCLC
Percy Lee, Professor and Vice-Chair of Clinical Research at City of Hope, shared on X/Twitter:…
Jan 22, 2024, 09:50 |
Blog
Wei Zhang: Glad to see IGFBP2 as the top plasma marker for early cancer detection of 18 types of solid tumors
Wei Zhang, Director of Cancer Genomics and Precision Oncology, shared on LinkedIn: ''Early Cancer Detection…
Jan 9, 2024, 11:37 |
Insight
Bob Li: This year will be pivotal for the world, with impact on shaping history for the rest of the 21st century
Bob Li, Chief Scientific Officer at Memorial Sloan Kettering Cancer Center, shared on LinkedIn: "International…
Jan 8, 2024, 10:12 |
Blog
Sunil Verma: A great way to kick off 2024 by attending JPM2024
Sunil Verma, Global Head of Oncology of Medical AstraZeneca, shared a post on LinkedIn: ''A…
Nov 18, 2023, 17:16 |
Blog
Leon 'Jun' T.: A few interesting observations from the top 25 antibody drug conjugates bone marrow deals
Leon 'Jun' T., Scientific Advisor at Mianus Capital, shared on LinkedIn: "Updated on 2023-11-10 by…
Nov 2, 2023, 01:12 |
Blog
Cristian Massacesi: I never fail to be impressed by my teams’ commitment in delivering science
Cristian Massacesi, Chief Medical Officer & Oncology Chief Development Officer at AstraZeneca, made the following…
Oct 29, 2023, 17:07 |
Blog
David Fredrickson: When it comes to driving breakthroughs in cancer care, curiosity is a superpower
David Fredrickson, Executive Vice-President of Oncology Business at AstraZeneca, shared a post on LinkedIn: "When…
Oct 26, 2023, 09:27 |
Opinion
Maurizio Scaltriti: What stands out at ESMO23 is the critical role that innovative trial design, early mechanistic studies and ongoing translational analysis play in informing treatment strategy
Oct 18, 2023, 16:08 |
Blog
Harold Cottin: City Cancer Challenge is very proud to partner with the World Health Organization for the implementation of the Global Breast Cancer Initiative
Quoting Harold Cottin, Head of Global Public Affairs at City Cancer Challenge, on LinkedIn: "City…
Sep 29, 2023, 18:43 |
Blog
Cristian Massacesi: Just completed another inspiring trip – this time to China and Taiwan – to meet up with AstraZeneca colleagues and connect with local clinical researchers conducting trials into potential new cancer treatments.
Sep 25, 2023, 15:17 |
Insight
Jason A. Mouabbi: Another ADC promises to broaden the treatment horizon in HR+ metastatic breast cancer.
Jason A. Mouabbi, Assistant Professor at MD Anderson Cancer Center, made the following post on X/Twitter:…
Sep 15, 2023, 18:40 |
Blog
Warm welcome and congratulations to CancerX’s inaugural steering committee, which provides an additional layer of governance within our public-private partnership model. - CancerX Moonshot
Aug 16, 2023, 18:22 |
Opinion
Anas Younes: Interesting report, although I disagree with some of the comments.
In a LinkedIn post, Anas Younes, Senior VP, Global Head of Hematology (Early and Late…
Aug 10, 2023, 20:21 |
Career
I’m starting a new position as Global Director, Early Cancer Detection and Screening at AstraZeneca - Sarah M. Dunlap
I’m happy to share that I’m starting a new position as Global Director, Early Cancer…
Jun 22, 2023, 19:15 |
Positive
We are at a pivotal time for treatment innovations in hematological malignancies - Anas Younes
We are at a pivotal time for treatment innovations in hematological malignancies, and our data…
Jun 12, 2023, 03:13 |
Drugs
The third country worldwide to approve this medication for HCC in combination with Durvalumab - Prof.Humaid Al-Shamsi
Last night in Dubai , in collaboration with AstraZeneca we successfully launched tremelimumab for the treatment of…
May 27, 2023, 14:11 |
Societies
It’s time to put this collective action into practice to improve the lives of cancer patients around the world - Isabel Mestres
What a week! On Monday, we officially announced City Cancer Challenge is joining forces with the World Health…
May 25, 2023, 16:11 |
Societies
At ESMO Breast we witnessed the true power of co-creation and cross-functional collaboration - Nana Scotto
Another great week closes for the whole of the Breast Cancer community following the ESMO…
May 14, 2023, 17:36 |
Career
Olivier Nataf joins Sanofi as Global Head of Oncology
Quoting Olivier Nataf on Linkedin, "A dreamjob is often hard to define and even more…
All:
94
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube